Literature DB >> 29034775

Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma.

Young Mi Hong1, Mong Cho1, Ki Tae Yoon1, Chong Woo Chu2, Kwang Ho Yang2, Yong Mok Park2, Je Ho Rhu2.   

Abstract

Early recurrence is common after curative hepatectomy for hepatocellular carcinoma and is associated with poor prognosis. This study aimed to identify risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma. Overall, 63 patients who underwent curative hepatectomy for hepatocellular carcinoma were enrolled. Patients were divided into the early recurrence group, who developed recurrence within 12 months after hepatectomy (n = 10), and the non-early recurrence group (n = 53). Clinicopathological factors of early recurrence were retrospectively analyzed. Among the 63 patients, 10 (15.9%) patients experienced early recurrence. Univariate analysis showed tumor necrosis (p = 0.012), level of PIVKA-II (prothrombin induced by vitamin K absence or antagonist-II; p = 0.002), and microvascular invasion (p = 0.029) to be associated with early recurrence. By multivariate analysis, there were significant differences in high PIVKA-II (p < 0.001) and tumor necrosis (p = 0.012) in patients with early recurrence. The optimal cutoff values of PIVKA-II and tumor necrosis were 46 mAU/mL and 3% of total tumor volume, respectively. Patients with a high preoperative PIVKA-II level and extent of tumor necrosis, which are independent risk factors for early recurrence, should be actively treated and monitored closely after hepatectomy.

Entities:  

Keywords:  Hepatocellular carcinoma; hepatectomy; prothrombin induced by vitamin K absence or antagonist-II; recurrence; tumor necrosis

Mesh:

Substances:

Year:  2017        PMID: 29034775     DOI: 10.1177/1010428317720863

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  10 in total

1.  Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma.

Authors:  Sung-Mi Jung; Jong Man Kim; Gyu-Seong Choi; Choon Hyuck David Kwon; Nam-Joon Yi; Kwang-Woong Lee; Kyung Suk Suh; Jae-Won Joh
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

2.  Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression.

Authors:  Hyungjin Rhee; Taek Chung; Jeong Eun Yoo; Ji Hae Nahm; Ha Young Woo; Gi Hong Choi; Dai Hoon Han; Young Nyun Park
Journal:  Hepatol Int       Date:  2020-01-29       Impact factor: 6.047

3.  Development and Validation of a Clinicopathological-Based Nomogram to Predict the Survival Outcome of Patients with Recurrent Hepatocellular Carcinoma After Hepatectomy Who Underwent Microwave Ablation.

Authors:  Chunhou Qi; Shankai Li; Lei Zhang
Journal:  Cancer Manag Res       Date:  2020-08-21       Impact factor: 3.989

4.  LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma.

Authors:  Hongbin Zhang; Ke Xu; Qin Xiang; Lijuan Zhao; Benxu Tan; Ping Ju; Xiufu Lan; Yi Liu; Jian Zhang; Zheng Fu; Chao Li; Jinzhi Wang; Jixiang Song; Yun Xiao; Zhaobo Cheng; Yan Wang; Shu Zhang; Tingxiu Xiang
Journal:  Genes Dis       Date:  2020-07-21

5.  The Benefit of Apparent Diffusion Coefficient in Evaluating the Invasiveness of Hepatocellular Carcinoma.

Authors:  Mengyuan Jing; Yuntai Cao; Peng Zhang; Bin Zhang; Xiaoqiang Lin; Liangna Deng; Tao Han; Junlin Zhou
Journal:  Front Oncol       Date:  2021-08-24       Impact factor: 6.244

6.  Impact of prognostic nutritional index on the recurrence of hepatocellular carcinoma after a curative resection.

Authors:  Ho Jeong; Kil Hwan Kim; Sungho Jo; Sanghyun Song
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-11-30

7.  Factors Associated with Recurrence of Hepatocellular Carcinoma in 197 Patients Following Transarterial Chemoembolization: A Retrospective Study from a Single Center.

Authors:  Hongsheng Zhang; Xiaodong Zhao; Wenhai Yu
Journal:  Med Sci Monit       Date:  2021-09-17

8.  Construction of a predictive nomogram and bioinformatic investigation of the potential mechanism of postoperative early recurrence of hepatocellular carcinoma meeting the Milan criteria.

Authors:  Shuqi Zhang; Liangliang Xu; Fuzhen Dai; Peng Wang; Jianchen Luo; Ming Zhang; Mingqing Xu
Journal:  Ann Transl Med       Date:  2022-08

Review 9.  Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation.

Authors:  Maria J Citores; Jose L Lucena; Sara de la Fuente; Valentin Cuervas-Mons
Journal:  World J Hepatol       Date:  2019-01-27

Review 10.  Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?

Authors:  Tsuyoshi Shimamura; Ryoichi Goto; Masaaki Watanabe; Norio Kawamura; Yasutsugu Takada
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.